Method for removing and reducing hepatitis C virus

   
   

Described is a method of removing and reducing HCV from the blood of an HCV-infected patient, which comprises carrying out, once a day for at least 5 straight days, a treatment of bringing the blood into contact with an adsorptive carrier having a higher affinity for infected, activated and/or defective leukocytes than for uninfected leukocytes. The treatment according to the present invention makes it possible to markedly reduce the blood HCV level of a patient suffering from Hepatitis C, thereby enabling antiviral therapy, for example, treatment with interferon. This brings a drastic improvement in the cure rate for Hepatitis C.

Se describe un método de quitar y de reducir HCV de la sangre de un paciente de HCV-infected, que abarca realizar, una vez al día por por lo menos 5 días rectos, un tratamiento de traer la sangre en contacto con un portador adsorbente que tiene leucocitos infectados, activados y/o defectuosos de una afinidad más alta para que para los leucocitos no infectados. El tratamiento según la actual invención permite reducir marcado el nivel de la sangre HCV de un paciente que sufre de la hepatitis C, de tal modo permitiendo la terapia antivirus, por ejemplo, tratamiento con interferón. Esto trae una mejora drástica en la tarifa de la curación para la hepatitis C.

 
Web www.patentalert.com

< Viral particles which are released after the infection with the human cytomegalovirus, and the use of said particles as a vaccine

< Inhibitors of hepatitis C virus

> Immunodominant human T-cell epitopes of hepatitis C virus

> Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions

~ 00106